+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Pharmacovigilance & Drug Safety Software Market Intelligence Report - Global Forecast to 2027- Product Image
Pharmacovigilance & Drug Safety Software Market Intelligence Report - Global Forecast to 2027- Product Image
Sale

Pharmacovigilance & Drug Safety Software Market Intelligence Report - Global Forecast to 2027

  • PDF Icon

    Report

  • 114 Pages
  • July 2022
  • Region: Global
  • Think Market Intelligence
  • ID: 5623935
UP TO OFF until Dec 31st 2022
Description Jump to:
The Global Pharmacovigilance & Drug Safety Software Market is projected to reach USD 940.58 million by 2027 from USD 426.74 million in 2021, at a CAGR 14.07% during the forecast period.

Market Statistics:


The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available.

In this report, the years 2019 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

  • The Americas Pharmacovigilance & Drug Safety Software Market size was estimated at USD 169.55 million in 2021, is expected to reach USD 189.13 million in 2022, and is projected to grow at a CAGR of 13.37% to reach USD 360.12 million by 2027.
  • The Asia-Pacific Pharmacovigilance & Drug Safety Software Market size was estimated at USD 99.09 million in 2021, is expected to reach USD 115.28 million in 2022, and is projected to grow at a CAGR of 14.94% to reach USD 228.61 million by 2027.
  • The Europe, Middle East & Africa Pharmacovigilance & Drug Safety Software Market size was estimated at USD 158.09 million in 2021, is expected to reach USD 180.55 million in 2022, and is projected to grow at a CAGR of 14.26% to reach USD 351.84 million by 2027.

Market Segmentation & Coverage:


The report on pharmacovigilance & drug safety software identifies key attributes about the customer to define the potential market and identify different needs across the industry. Understanding the potential customer group's economies and geographies can help gain business acumen for better strategic decision-making. This market coverage across different industry verticals reveals the hidden truth about the players' strategies in different verticals and helps the organization decide target audience. This report gives you the composite view of sub-markets coupled with comprehensive industry coverage and provides you with the right way of accounting factors such as norms & regulations, culture, to make right coverage strategy for your market plan.

This research report categorizes the pharmacovigilance & drug safety software to forecast the revenues and analyze the trends in each of the following sub-markets:

Product:

  • Adverse Event Reporting Software
  • Drug Safety Audits Software
  • Fully Integrated Software
  • Issue Tracking Software

Clinical Trial:

  • Phase I
  • Phase II
  • Phase III
  • Phase IV
  • Pre-clinical

Distribution:

  • On-Cloud
  • On-Premise

End User:

  • Business Process Outsourcing Firms
  • Contract Research Organizations
  • Pharma & Biotech Companies
  • Pharmacovigilance Service Providers

Region:

  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • Arkansas
      • California
      • Florida
      • Illinois
      • Kentucky
      • Minnesota
      • New Jersey
      • New Mexico
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
  • Europe, Middle East & Africa
    • France
    • Germany
    • Italy
    • Netherlands
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • United Arab Emirates
    • United Kingdom

Company Usability Profiles:

  • 4C Pharma Solutions
  • AB Cube
  • Accenture PLC
  • Advera Health Analytics, Inc.
  • Anju Software, Inc.
  • ArisGlobal LLC
  • Clinevo Technologies Private Limited
  • Cognizant Technology Solutions Corporation
  • Ennov
  • Ergomed PLC
  • Extedo GmbH
  • Indegene Inc.
  • IQVIA Inc.
  • Oracle Corporation
  • Sarjen Systems Private Limited
  • Sparta Systems, Inc.
  • United BioSource LLC
  • Wipro Limited
Frequently Asked Questions about the Pharmacovigilance & Drug Safety Software Market

What is the estimated value of the Pharmacovigilance & Drug Safety Software Market?

The Pharmacovigilance & Drug Safety Software Market was estimated to be valued at $426.74 Million in 2021.

What is the growth rate of the Pharmacovigilance & Drug Safety Software Market?

The growth rate of the Pharmacovigilance & Drug Safety Software Market is 14.0%, with an estimated value of $940.58 Million by 2027.

What is the forecasted size of the Pharmacovigilance & Drug Safety Software Market?

The Pharmacovigilance & Drug Safety Software Market is estimated to be worth $940.58 Million by 2027.

Who are the key companies in the Pharmacovigilance & Drug Safety Software Market?

Key companies in the Pharmacovigilance & Drug Safety Software Market include 4C Pharma Solutions, AB Cube, Accenture PLC, Advera Health Analytics, Inc., Anju Software, Inc., ArisGlobal LLC, Clinevo Technologies Private Limited, Cognizant Technology Solutions Corporation and Ergomed PLC.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Market Overview
4. Americas Pharmacovigilance & Drug Safety Software Market
4.1. Introduction
4.2. Argentina
4.3. Brazil
4.4. Canada
4.5. Mexico
4.6. United States
5. Asia-Pacific Pharmacovigilance & Drug Safety Software Market
5.1. Introduction
5.2. Australia
5.3. China
5.4. India
5.5. Indonesia
5.6. Japan
5.7. Malaysia
5.8. Philippines
5.9. Singapore
5.10. South Korea
5.11. Taiwan
5.12. Thailand
6. Europe, Middle East & Africa Pharmacovigilance & Drug Safety Software Market
6.1. Introduction
6.2. France
6.3. Germany
6.4. Italy
6.5. Netherlands
6.6. Qatar
6.7. Russia
6.8. Saudi Arabia
6.9. South Africa
6.10. Spain
6.11. United Arab Emirates
6.12. United Kingdom
7. Company Usability Profiles
7.1. 4C Pharma Solutions
7.2. AB Cube
7.3. Accenture PLC
7.4. Advera Health Analytics, Inc.
7.5. Anju Software, Inc.
7.6. ArisGlobal LLC
7.7. Clinevo Technologies Private Limited
7.8. Cognizant Technology Solutions Corporation
7.9. Ennov
7.10. Ergomed PLC
7.11. Extedo GmbH
7.12. Indegene Inc.
7.13. IQVIA Inc.
7.14. Oracle Corporation
7.15. Sarjen Systems Private Limited
7.16. Sparta Systems, Inc.
7.17. United BioSource LLC
7.18. Wipro Limited
List of Figures
Figure 1. Global Pharmacovigilance & Drug Safety Software Market: Research Process
Figure 2. Global Pharmacovigilance & Drug Safety Software Market Size, 2019-2027 (USD Million)
Figure 3. Global Pharmacovigilance & Drug Safety Software Market Size, by Region, 2021 Vs 2027 (%)
Figure 4. Global Pharmacovigilance & Drug Safety Software Market Size, by Region, 2021 Vs 2027 (USD Million)
Figure 5. Competitive Strategic Window For Global Pharmacovigilance & Drug Safety Software Market Size, by Region, 2027
Figure 6. Americas Pharmacovigilance & Drug Safety Software Market Size, 2019-2027 (USD Million)
Figure 7. Americas Pharmacovigilance & Drug Safety Software Market Size, by Country, 2021 Vs 2027 (%)
Figure 8. Americas Pharmacovigilance & Drug Safety Software Market Size, by Country, 2021 Vs 2027 (USD Million)
Figure 9. Competitive Strategic Window For Americas Pharmacovigilance & Drug Safety Software Market Size, by Country, 2027
Figure 10. Argentina Pharmacovigilance & Drug Safety Software Market Size, 2019-2027 (USD Million)
Figure 11. Brazil Pharmacovigilance & Drug Safety Software Market Size, 2019-2027 (USD Million)
Figure 12. Canada Pharmacovigilance & Drug Safety Software Market Size, 2019-2027 (USD Million)
Figure 13. Mexico Pharmacovigilance & Drug Safety Software Market Size, 2019-2027 (USD Million)
Figure 14. United States Pharmacovigilance & Drug Safety Software Market Size, 2019-2027 (USD Million)
Figure 15. United States Pharmacovigilance & Drug Safety Software Market Size, by State, 2021 Vs 2027 (%)
Figure 16. United States Pharmacovigilance & Drug Safety Software Market Size, by State, 2021 Vs 2027 (USD Million)
Figure 17. Competitive Strategic Window For United States Pharmacovigilance & Drug Safety Software Market Size, by State, 2027
Figure 18. Asia-Pacific Pharmacovigilance & Drug Safety Software Market Size, 2019-2027 (USD Million)
Figure 19. Asia-Pacific Pharmacovigilance & Drug Safety Software Market Size, by Country, 2021 Vs 2027 (%)
Figure 20. Asia-Pacific Pharmacovigilance & Drug Safety Software Market Size, by Country, 2021 Vs 2027 (USD Million)
Figure 21. Competitive Strategic Window For Asia-Pacific Pharmacovigilance & Drug Safety Software Market Size, by Country, 2027
Figure 22. Australia Pharmacovigilance & Drug Safety Software Market Size, 2019-2027 (USD Million)
Figure 23. China Pharmacovigilance & Drug Safety Software Market Size, 2019-2027 (USD Million)
Figure 24. India Pharmacovigilance & Drug Safety Software Market Size, 2019-2027 (USD Million)
Figure 25. Indonesia Pharmacovigilance & Drug Safety Software Market Size, 2019-2027 (USD Million)
Figure 26. Japan Pharmacovigilance & Drug Safety Software Market Size, 2019-2027 (USD Million)
Figure 27. Malaysia Pharmacovigilance & Drug Safety Software Market Size, 2019-2027 (USD Million)
Figure 28. Philippines Pharmacovigilance & Drug Safety Software Market Size, 2019-2027 (USD Million)
Figure 29. Singapore Pharmacovigilance & Drug Safety Software Market Size, 2019-2027 (USD Million)
Figure 30. South Korea Pharmacovigilance & Drug Safety Software Market Size, 2019-2027 (USD Million)
Figure 31. Taiwan Pharmacovigilance & Drug Safety Software Market Size, 2019-2027 (USD Million)
Figure 32. Thailand Pharmacovigilance & Drug Safety Software Market Size, 2019-2027 (USD Million)
Figure 33. Europe, Middle East & Africa Pharmacovigilance & Drug Safety Software Market Size, 2019-2027 (USD Million)
Figure 34. Europe, Middle East & Africa Pharmacovigilance & Drug Safety Software Market Size, by Country, 2021 Vs 2027 (%)
Figure 35. Europe, Middle East & Africa Pharmacovigilance & Drug Safety Software Market Size, by Country, 2021 Vs 2027 (USD Million)
Figure 36. Competitive Strategic Window For Europe, Middle East & Africa Pharmacovigilance & Drug Safety Software Market Size, by Country, 2027
Figure 37. France Pharmacovigilance & Drug Safety Software Market Size, 2019-2027 (USD Million)
Figure 38. Germany Pharmacovigilance & Drug Safety Software Market Size, 2019-2027 (USD Million)
Figure 39. Italy Pharmacovigilance & Drug Safety Software Market Size, 2019-2027 (USD Million)
Figure 40. Netherlands Pharmacovigilance & Drug Safety Software Market Size, 2019-2027 (USD Million)
Figure 41. Qatar Pharmacovigilance & Drug Safety Software Market Size, 2019-2027 (USD Million)
Figure 42. Russia Pharmacovigilance & Drug Safety Software Market Size, 2019-2027 (USD Million)
Figure 43. Saudi Arabia Pharmacovigilance & Drug Safety Software Market Size, 2019-2027 (USD Million)
Figure 44. South Africa Pharmacovigilance & Drug Safety Software Market Size, 2019-2027 (USD Million)
Figure 45. Spain Pharmacovigilance & Drug Safety Software Market Size, 2019-2027 (USD Million)
Figure 46. United Arab Emirates Pharmacovigilance & Drug Safety Software Market Size, 2019-2027 (USD Million)
Figure 47. United Kingdom Pharmacovigilance & Drug Safety Software Market Size, 2019-2027 (USD Million)
List of Tables
Table 1. Global Pharmacovigilance & Drug Safety Software Market Segmentation & Coverage
Table 2. United States Dollar Exchange Rate, 2016-2020
Table 3. Global Pharmacovigilance & Drug Safety Software Market Size, 2019-2027 (USD Million)
Table 4. Global Pharmacovigilance & Drug Safety Software Market Size, by Region, 2019-2027 (USD Million)
Table 5. Global Pharmacovigilance & Drug Safety Software Market Size, by Product, 2019-2027 (USD Million)
Table 6. Global Pharmacovigilance & Drug Safety Software Market Size, by Clinical Trial, 2019-2027 (USD Million)
Table 7. Global Pharmacovigilance & Drug Safety Software Market Size, by Distribution, 2019-2027 (USD Million)
Table 8. Global Pharmacovigilance & Drug Safety Software Market Size, by End User, 2019-2027 (USD Million)
Table 9. Americas Pharmacovigilance & Drug Safety Software Market Size, 2019-2027 (USD Million)
Table 10. Americas Pharmacovigilance & Drug Safety Software Market Size, by Country, 2019-2027 (USD Million)
Table 11. Americas Pharmacovigilance & Drug Safety Software Market Size, by Product, 2019-2027 (USD Million)
Table 12. Americas Pharmacovigilance & Drug Safety Software Market Size, by Clinical Trial, 2019-2027 (USD Million)
Table 13. Americas Pharmacovigilance & Drug Safety Software Market Size, by Distribution, 2019-2027 (USD Million)
Table 14. Americas Pharmacovigilance & Drug Safety Software Market Size, by End User, 2019-2027 (USD Million)
Table 15. Argentina Pharmacovigilance & Drug Safety Software Market Size, 2019-2027 (USD Million)
Table 16. Argentina Pharmacovigilance & Drug Safety Software Market Size, by Product, 2019-2027 (USD Million)
Table 17. Argentina Pharmacovigilance & Drug Safety Software Market Size, by Clinical Trial, 2019-2027 (USD Million)
Table 18. Argentina Pharmacovigilance & Drug Safety Software Market Size, by Distribution, 2019-2027 (USD Million)
Table 19. Argentina Pharmacovigilance & Drug Safety Software Market Size, by End User, 2019-2027 (USD Million)
Table 20. Brazil Pharmacovigilance & Drug Safety Software Market Size, 2019-2027 (USD Million)
Table 21. Brazil Pharmacovigilance & Drug Safety Software Market Size, by Product, 2019-2027 (USD Million)
Table 22. Brazil Pharmacovigilance & Drug Safety Software Market Size, by Clinical Trial, 2019-2027 (USD Million)
Table 23. Brazil Pharmacovigilance & Drug Safety Software Market Size, by Distribution, 2019-2027 (USD Million)
Table 24. Brazil Pharmacovigilance & Drug Safety Software Market Size, by End User, 2019-2027 (USD Million)
Table 25. Canada Pharmacovigilance & Drug Safety Software Market Size, 2019-2027 (USD Million)
Table 26. Canada Pharmacovigilance & Drug Safety Software Market Size, by Product, 2019-2027 (USD Million)
Table 27. Canada Pharmacovigilance & Drug Safety Software Market Size, by Clinical Trial, 2019-2027 (USD Million)
Table 28. Canada Pharmacovigilance & Drug Safety Software Market Size, by Distribution, 2019-2027 (USD Million)
Table 29. Canada Pharmacovigilance & Drug Safety Software Market Size, by End User, 2019-2027 (USD Million)
Table 30. Mexico Pharmacovigilance & Drug Safety Software Market Size, 2019-2027 (USD Million)
Table 31. Mexico Pharmacovigilance & Drug Safety Software Market Size, by Product, 2019-2027 (USD Million)
Table 32. Mexico Pharmacovigilance & Drug Safety Software Market Size, by Clinical Trial, 2019-2027 (USD Million)
Table 33. Mexico Pharmacovigilance & Drug Safety Software Market Size, by Distribution, 2019-2027 (USD Million)
Table 34. Mexico Pharmacovigilance & Drug Safety Software Market Size, by End User, 2019-2027 (USD Million)
Table 35. United States Pharmacovigilance & Drug Safety Software Market Size, 2019-2027 (USD Million)
Table 36. United States Pharmacovigilance & Drug Safety Software Market Size, by State, 2019-2027 (USD Million)
Table 37. United States Pharmacovigilance & Drug Safety Software Market Size, by Product, 2019-2027 (USD Million)
Table 38. United States Pharmacovigilance & Drug Safety Software Market Size, by Clinical Trial, 2019-2027 (USD Million)
Table 39. United States Pharmacovigilance & Drug Safety Software Market Size, by Distribution, 2019-2027 (USD Million)
Table 40. United States Pharmacovigilance & Drug Safety Software Market Size, by End User, 2019-2027 (USD Million)
Table 41. Asia-Pacific Pharmacovigilance & Drug Safety Software Market Size, 2019-2027 (USD Million)
Table 42. Asia-Pacific Pharmacovigilance & Drug Safety Software Market Size, by Country, 2019-2027 (USD Million)
Table 43. Asia-Pacific Pharmacovigilance & Drug Safety Software Market Size, by Product, 2019-2027 (USD Million)
Table 44. Asia-Pacific Pharmacovigilance & Drug Safety Software Market Size, by Clinical Trial, 2019-2027 (USD Million)
Table 45. Asia-Pacific Pharmacovigilance & Drug Safety Software Market Size, by Distribution, 2019-2027 (USD Million)
Table 46. Asia-Pacific Pharmacovigilance & Drug Safety Software Market Size, by End User, 2019-2027 (USD Million)
Table 47. Australia Pharmacovigilance & Drug Safety Software Market Size, 2019-2027 (USD Million)
Table 48. Australia Pharmacovigilance & Drug Safety Software Market Size, by Product, 2019-2027 (USD Million)
Table 49. Australia Pharmacovigilance & Drug Safety Software Market Size, by Clinical Trial, 2019-2027 (USD Million)
Table 50. Australia Pharmacovigilance & Drug Safety Software Market Size, by Distribution, 2019-2027 (USD Million)
Table 51. Australia Pharmacovigilance & Drug Safety Software Market Size, by End User, 2019-2027 (USD Million)
Table 52. China Pharmacovigilance & Drug Safety Software Market Size, 2019-2027 (USD Million)
Table 53. China Pharmacovigilance & Drug Safety Software Market Size, by Product, 2019-2027 (USD Million)
Table 54. China Pharmacovigilance & Drug Safety Software Market Size, by Clinical Trial, 2019-2027 (USD Million)
Table 55. China Pharmacovigilance & Drug Safety Software Market Size, by Distribution, 2019-2027 (USD Million)
Table 56. China Pharmacovigilance & Drug Safety Software Market Size, by End User, 2019-2027 (USD Million)
Table 57. India Pharmacovigilance & Drug Safety Software Market Size, 2019-2027 (USD Million)
Table 58. India Pharmacovigilance & Drug Safety Software Market Size, by Product, 2019-2027 (USD Million)
Table 59. India Pharmacovigilance & Drug Safety Software Market Size, by Clinical Trial, 2019-2027 (USD Million)
Table 60. India Pharmacovigilance & Drug Safety Software Market Size, by Distribution, 2019-2027 (USD Million)
Table 61. India Pharmacovigilance & Drug Safety Software Market Size, by End User, 2019-2027 (USD Million)
Table 62. Indonesia Pharmacovigilance & Drug Safety Software Market Size, 2019-2027 (USD Million)
Table 63. Indonesia Pharmacovigilance & Drug Safety Software Market Size, by Product, 2019-2027 (USD Million)
Table 64. Indonesia Pharmacovigilance & Drug Safety Software Market Size, by Clinical Trial, 2019-2027 (USD Million)
Table 65. Indonesia Pharmacovigilance & Drug Safety Software Market Size, by Distribution, 2019-2027 (USD Million)
Table 66. Indonesia Pharmacovigilance & Drug Safety Software Market Size, by End User, 2019-2027 (USD Million)
Table 67. Japan Pharmacovigilance & Drug Safety Software Market Size, 2019-2027 (USD Million)
Table 68. Japan Pharmacovigilance & Drug Safety Software Market Size, by Product, 2019-2027 (USD Million)
Table 69. Japan Pharmacovigilance & Drug Safety Software Market Size, by Clinical Trial, 2019-2027 (USD Million)
Table 70. Japan Pharmacovigilance & Drug Safety Software Market Size, by Distribution, 2019-2027 (USD Million)
Table 71. Japan Pharmacovigilance & Drug Safety Software Market Size, by End User, 2019-2027 (USD Million)
Table 72. Malaysia Pharmacovigilance & Drug Safety Software Market Size, 2019-2027 (USD Million)
Table 73. Malaysia Pharmacovigilance & Drug Safety Software Market Size, by Product, 2019-2027 (USD Million)
Table 74. Malaysia Pharmacovigilance & Drug Safety Software Market Size, by Clinical Trial, 2019-2027 (USD Million)
Table 75. Malaysia Pharmacovigilance & Drug Safety Software Market Size, by Distribution, 2019-2027 (USD Million)
Table 76. Malaysia Pharmacovigilance & Drug Safety Software Market Size, by End User, 2019-2027 (USD Million)
Table 77. Philippines Pharmacovigilance & Drug Safety Software Market Size, 2019-2027 (USD Million)
Table 78. Philippines Pharmacovigilance & Drug Safety Software Market Size, by Product, 2019-2027 (USD Million)
Table 79. Philippines Pharmacovigilance & Drug Safety Software Market Size, by Clinical Trial, 2019-2027 (USD Million)
Table 80. Philippines Pharmacovigilance & Drug Safety Software Market Size, by Distribution, 2019-2027 (USD Million)
Table 81. Philippines Pharmacovigilance & Drug Safety Software Market Size, by End User, 2019-2027 (USD Million)
Table 82. Singapore Pharmacovigilance & Drug Safety Software Market Size, 2019-2027 (USD Million)
Table 83. Singapore Pharmacovigilance & Drug Safety Software Market Size, by Product, 2019-2027 (USD Million)
Table 84. Singapore Pharmacovigilance & Drug Safety Software Market Size, by Clinical Trial, 2019-2027 (USD Million)
Table 85. Singapore Pharmacovigilance & Drug Safety Software Market Size, by Distribution, 2019-2027 (USD Million)
Table 86. Singapore Pharmacovigilance & Drug Safety Software Market Size, by End User, 2019-2027 (USD Million)
Table 87. South Korea Pharmacovigilance & Drug Safety Software Market Size, 2019-2027 (USD Million)
Table 88. South Korea Pharmacovigilance & Drug Safety Software Market Size, by Product, 2019-2027 (USD Million)
Table 89. South Korea Pharmacovigilance & Drug Safety Software Market Size, by Clinical Trial, 2019-2027 (USD Million)
Table 90. South Korea Pharmacovigilance & Drug Safety Software Market Size, by Distribution, 2019-2027 (USD Million)
Table 91. South Korea Pharmacovigilance & Drug Safety Software Market Size, by End User, 2019-2027 (USD Million)
Table 92. Taiwan Pharmacovigilance & Drug Safety Software Market Size, 2019-2027 (USD Million)
Table 93. Taiwan Pharmacovigilance & Drug Safety Software Market Size, by Product, 2019-2027 (USD Million)
Table 94. Taiwan Pharmacovigilance & Drug Safety Software Market Size, by Clinical Trial, 2019-2027 (USD Million)
Table 95. Taiwan Pharmacovigilance & Drug Safety Software Market Size, by Distribution, 2019-2027 (USD Million)
Table 96. Taiwan Pharmacovigilance & Drug Safety Software Market Size, by End User, 2019-2027 (USD Million)
Table 97. Thailand Pharmacovigilance & Drug Safety Software Market Size, 2019-2027 (USD Million)
Table 98. Thailand Pharmacovigilance & Drug Safety Software Market Size, by Product, 2019-2027 (USD Million)
Table 99. Thailand Pharmacovigilance & Drug Safety Software Market Size, by Clinical Trial, 2019-2027 (USD Million)
Table 100. Thailand Pharmacovigilance & Drug Safety Software Market Size, by Distribution, 2019-2027 (USD Million)
Table 101. Thailand Pharmacovigilance & Drug Safety Software Market Size, by End User, 2019-2027 (USD Million)
Table 102. Europe, Middle East & Africa Pharmacovigilance & Drug Safety Software Market Size, 2019-2027 (USD Million)
Table 103. Europe, Middle East & Africa Pharmacovigilance & Drug Safety Software Market Size, by Country, 2019-2027 (USD Million)
Table 104. Europe, Middle East & Africa Pharmacovigilance & Drug Safety Software Market Size, by Product, 2019-2027 (USD Million)
Table 105. Europe, Middle East & Africa Pharmacovigilance & Drug Safety Software Market Size, by Clinical Trial, 2019-2027 (USD Million)
Table 106. Europe, Middle East & Africa Pharmacovigilance & Drug Safety Software Market Size, by Distribution, 2019-2027 (USD Million)
Table 107. Europe, Middle East & Africa Pharmacovigilance & Drug Safety Software Market Size, by End User, 2019-2027 (USD Million)
Table 108. France Pharmacovigilance & Drug Safety Software Market Size, 2019-2027 (USD Million)
Table 109. France Pharmacovigilance & Drug Safety Software Market Size, by Product, 2019-2027 (USD Million)
Table 110. France Pharmacovigilance & Drug Safety Software Market Size, by Clinical Trial, 2019-2027 (USD Million)
Table 111. France Pharmacovigilance & Drug Safety Software Market Size, by Distribution, 2019-2027 (USD Million)
Table 112. France Pharmacovigilance & Drug Safety Software Market Size, by End User, 2019-2027 (USD Million)
Table 113. Germany Pharmacovigilance & Drug Safety Software Market Size, 2019-2027 (USD Million)
Table 114. Germany Pharmacovigilance & Drug Safety Software Market Size, by Product, 2019-2027 (USD Million)
Table 115. Germany Pharmacovigilance & Drug Safety Software Market Size, by Clinical Trial, 2019-2027 (USD Million)
Table 116. Germany Pharmacovigilance & Drug Safety Software Market Size, by Distribution, 2019-2027 (USD Million)
Table 117. Germany Pharmacovigilance & Drug Safety Software Market Size, by End User, 2019-2027 (USD Million)
Table 118. Italy Pharmacovigilance & Drug Safety Software Market Size, 2019-2027 (USD Million)
Table 119. Italy Pharmacovigilance & Drug Safety Software Market Size, by Product, 2019-2027 (USD Million)
Table 120. Italy Pharmacovigilance & Drug Safety Software Market Size, by Clinical Trial, 2019-2027 (USD Million)
Table 121. Italy Pharmacovigilance & Drug Safety Software Market Size, by Distribution, 2019-2027 (USD Million)
Table 122. Italy Pharmacovigilance & Drug Safety Software Market Size, by End User, 2019-2027 (USD Million)
Table 123. Netherlands Pharmacovigilance & Drug Safety Software Market Size, 2019-2027 (USD Million)
Table 124. Netherlands Pharmacovigilance & Drug Safety Software Market Size, by Product, 2019-2027 (USD Million)
Table 125. Netherlands Pharmacovigilance & Drug Safety Software Market Size, by Clinical Trial, 2019-2027 (USD Million)
Table 126. Netherlands Pharmacovigilance & Drug Safety Software Market Size, by Distribution, 2019-2027 (USD Million)
Table 127. Netherlands Pharmacovigilance & Drug Safety Software Market Size, by End User, 2019-2027 (USD Million)
Table 128. Qatar Pharmacovigilance & Drug Safety Software Market Size, 2019-2027 (USD Million)
Table 129. Qatar Pharmacovigilance & Drug Safety Software Market Size, by Product, 2019-2027 (USD Million)
Table 130. Qatar Pharmacovigilance & Drug Safety Software Market Size, by Clinical Trial, 2019-2027 (USD Million)
Table 131. Qatar Pharmacovigilance & Drug Safety Software Market Size, by Distribution, 2019-2027 (USD Million)
Table 132. Qatar Pharmacovigilance & Drug Safety Software Market Size, by End User, 2019-2027 (USD Million)
Table 133. Russia Pharmacovigilance & Drug Safety Software Market Size, 2019-2027 (USD Million)
Table 134. Russia Pharmacovigilance & Drug Safety Software Market Size, by Product, 2019-2027 (USD Million)
Table 135. Russia Pharmacovigilance & Drug Safety Software Market Size, by Clinical Trial, 2019-2027 (USD Million)
Table 136. Russia Pharmacovigilance & Drug Safety Software Market Size, by Distribution, 2019-2027 (USD Million)
Table 137. Russia Pharmacovigilance & Drug Safety Software Market Size, by End User, 2019-2027 (USD Million)
Table 138. Saudi Arabia Pharmacovigilance & Drug Safety Software Market Size, 2019-2027 (USD Million)
Table 139. Saudi Arabia Pharmacovigilance & Drug Safety Software Market Size, by Product, 2019-2027 (USD Million)
Table 140. Saudi Arabia Pharmacovigilance & Drug Safety Software Market Size, by Clinical Trial, 2019-2027 (USD Million)
Table 141. Saudi Arabia Pharmacovigilance & Drug Safety Software Market Size, by Distribution, 2019-2027 (USD Million)
Table 142. Saudi Arabia Pharmacovigilance & Drug Safety Software Market Size, by End User, 2019-2027 (USD Million)
Table 143. South Africa Pharmacovigilance & Drug Safety Software Market Size, 2019-2027 (USD Million)
Table 144. South Africa Pharmacovigilance & Drug Safety Software Market Size, by Product, 2019-2027 (USD Million)
Table 145. South Africa Pharmacovigilance & Drug Safety Software Market Size, by Clinical Trial, 2019-2027 (USD Million)
Table 146. South Africa Pharmacovigilance & Drug Safety Software Market Size, by Distribution, 2019-2027 (USD Million)
Table 147. South Africa Pharmacovigilance & Drug Safety Software Market Size, by End User, 2019-2027 (USD Million)
Table 148. Spain Pharmacovigilance & Drug Safety Software Market Size, 2019-2027 (USD Million)
Table 149. Spain Pharmacovigilance & Drug Safety Software Market Size, by Product, 2019-2027 (USD Million)
Table 150. Spain Pharmacovigilance & Drug Safety Software Market Size, by Clinical Trial, 2019-2027 (USD Million)
Table 151. Spain Pharmacovigilance & Drug Safety Software Market Size, by Distribution, 2019-2027 (USD Million)
Table 152. Spain Pharmacovigilance & Drug Safety Software Market Size, by End User, 2019-2027 (USD Million)
Table 153. United Arab Emirates Pharmacovigilance & Drug Safety Software Market Size, 2019-2027 (USD Million)
Table 154. United Arab Emirates Pharmacovigilance & Drug Safety Software Market Size, by Product, 2019-2027 (USD Million)
Table 155. United Arab Emirates Pharmacovigilance & Drug Safety Software Market Size, by Clinical Trial, 2019-2027 (USD Million)
Table 156. United Arab Emirates Pharmacovigilance & Drug Safety Software Market Size, by Distribution, 2019-2027 (USD Million)
Table 157. United Arab Emirates Pharmacovigilance & Drug Safety Software Market Size, by End User, 2019-2027 (USD Million)
Table 158. United Kingdom Pharmacovigilance & Drug Safety Software Market Size, 2019-2027 (USD Million)
Table 159. United Kingdom Pharmacovigilance & Drug Safety Software Market Size, by Product, 2019-2027 (USD Million)
Table 160. United Kingdom Pharmacovigilance & Drug Safety Software Market Size, by Clinical Trial, 2019-2027 (USD Million)
Table 161. United Kingdom Pharmacovigilance & Drug Safety Software Market Size, by Distribution, 2019-2027 (USD Million)
Table 162. United Kingdom Pharmacovigilance & Drug Safety Software Market Size, by End User, 2019-2027 (USD Million)

Companies Mentioned

  • 4C Pharma Solutions
  • AB Cube
  • Accenture PLC
  • Advera Health Analytics, Inc.
  • Anju Software, Inc.
  • ArisGlobal LLC
  • Clinevo Technologies Private Limited
  • Cognizant Technology Solutions Corporation
  • Ennov
  • Ergomed PLC
  • Extedo GmbH
  • Indegene Inc.
  • IQVIA Inc.
  • Oracle Corporation
  • Sarjen Systems Private Limited
  • Sparta Systems, Inc.
  • United BioSource LLC
  • Wipro Limited

Methodology

Loading
LOADING...

Related Topics

Related Reports

Pharmacovigilance & Drug Safety Software Market Research Report by Product, Clinical Trial, Distribution, End User, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19 - Product Image

Pharmacovigilance & Drug Safety Software Market Research Report by Product, Clinical Trial, Distribution, End User, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19

  • Report
  • 242 Pages
  • Region: Global
From
Pharmacovigilance and Drug Safety Software Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027 - Product Image

Pharmacovigilance and Drug Safety Software Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

  • Report
  • 143 Pages
  • Region: Global
From
Pharmacovigilance and Drug Safety Software Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027) - Product Image

Pharmacovigilance and Drug Safety Software Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

  • Report
  • 120 Pages
  • Region: Global
From
Pharmacovigilance Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027) - Product Image

Pharmacovigilance Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

  • Report
  • 125 Pages
  • Region: Global
From
Global Pharmacovigilance and Drug Safety Software Market 2021-2031 by Functionality, Clinical Phase, Method, Delivery Mode, Indication, End User, and Region: Trend Forecast and Growth Opportunity - Product Image

Global Pharmacovigilance and Drug Safety Software Market 2021-2031 by Functionality, Clinical Phase, Method, Delivery Mode, Indication, End User, and Region: Trend Forecast and Growth Opportunity

  • Report
  • 173 Pages
  • Region: Global
From
Copyright © 2002-2022 Research and Markets. All Rights Reserved.